PrognosDx Health, Inc. We are a biotechnology company aiming to significantly improve the treatment of cancer and other complex diseases through powerful epigenetic technology. We are currently aimed at providing CLIA-based laboratory developed tests enabling treating oncologists and urologists access clinically relevant independent Epigenetic information through identifying patients with low or high risk of recurrence of cancer so that the most appropriate course of treatment can be selected at the right time for the right patient.